Improvement of scalp and nail lesions with ixekizumab in a phase 2 trial in patients with chronic plaque psoriasis
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Improvement of scalp and nail lesions with ixekizumab in a phase 2 trial in patients with chronic plaque psoriasis
Authors
Keywords
-
Journal
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
Volume 29, Issue 9, Pages 1763-1770
Publisher
Wiley
Online
2015-02-19
DOI
10.1111/jdv.12996
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A 52-week, open-label study of the efficacy and safety of ixekizumab, an anti-interleukin-17A monoclonal antibody, in patients with chronic plaque psoriasis
- (2014) Kenneth B. Gordon et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Secukinumab improves hand, foot and nail lesions in moderate-to-severe plaque psoriasis: subanalysis of a randomized, double-blind, placebo-controlled, regimen-finding phase 2 trial
- (2014) C. Paul et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Adalimumab for the treatment of moderate to severe psoriasis: subanalysis of effects on scalp and nails in the BELIEVE study
- (2014) D. Thaçi et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Nail Psoriasis, the unknown burden of disease
- (2014) K.M.G. Klaassen et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Ustekinumab improves nail disease in patients with moderate-to-severe psoriasis: results from PHOENIX 1
- (2013) P. Rich et al. BRITISH JOURNAL OF DERMATOLOGY
- Biologic agents in nail psoriasis: efficacy data and considerations
- (2013) Aikaterini Kyriakou et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- A 24-week randomized clinical trial investigating the efficacy and safety of two doses of etanercept in nail psoriasis
- (2012) J.P. Ortonne et al. BRITISH JOURNAL OF DERMATOLOGY
- Anti–Interleukin-17 Monoclonal Antibody Ixekizumab in Chronic Plaque Psoriasis
- (2012) Craig Leonardi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Moderate to severe plaque psoriasis with scalp involvement: A randomized, double-blind, placebo-controlled study of etanercept
- (2011) Jerry Bagel et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Adalimumab for Treatment of Moderate to Severe Chronic Plaque Psoriasis of the Hands and Feet
- (2010) Craig Leonardi et al. ARCHIVES OF DERMATOLOGY
- Nail psoriasis in Germany: epidemiology and burden of disease
- (2010) M. Augustin et al. BRITISH JOURNAL OF DERMATOLOGY
- Skin and Nail Responses after 1 Year of Infliximab Therapy in Patients with Moderate-to-Severe Psoriasis: A Retrospective Analysis of the EXPRESS Trial
- (2010) Kristian Reich et al. DERMATOLOGY
- Nail psoriasis: a retrospective study on the effectiveness of systemic treatments (classical and biological therapy)
- (2010) M Sánchez-Regaña et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Sustained improvement in joint pain and nail symptoms with etanercept therapy in patients with moderate-to-severe psoriasis
- (2009) TA Luger et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Growth rate of human fingernails and toenails in healthy American young adults
- (2009) S Yaemsiri et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Evaluation of the efficacy and safety of infliximab on psoriatic nails: an unblinded, nonrandomized, open-label study
- (2008) D. Rigopoulos et al. BRITISH JOURNAL OF DERMATOLOGY
- Psoriasis treatment in difficult locations: scalp, nails, and intertriginous areas
- (2008) Gottfried Wozel CLINICS IN DERMATOLOGY
- The prevalence of previously diagnosed and undiagnosed psoriasis in US adults: Results from NHANES 2003-2004
- (2008) Shanu Kohli Kurd et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Baseline nail disease in patients with moderate to severe psoriasis and response to treatment with infliximab during 1 year
- (2007) Phoebe Rich et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started